1. Home
  2. CNTB vs KOSS Comparison

CNTB vs KOSS Comparison

Compare CNTB & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • KOSS
  • Stock Information
  • Founded
  • CNTB 2012
  • KOSS 1953
  • Country
  • CNTB United States
  • KOSS United States
  • Employees
  • CNTB N/A
  • KOSS N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • CNTB Health Care
  • KOSS Consumer Staples
  • Exchange
  • CNTB Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • CNTB 90.3M
  • KOSS 53.6M
  • IPO Year
  • CNTB 2021
  • KOSS N/A
  • Fundamental
  • Price
  • CNTB $1.73
  • KOSS $4.85
  • Analyst Decision
  • CNTB Strong Buy
  • KOSS
  • Analyst Count
  • CNTB 2
  • KOSS 0
  • Target Price
  • CNTB $7.50
  • KOSS N/A
  • AVG Volume (30 Days)
  • CNTB 100.0K
  • KOSS 46.0K
  • Earning Date
  • CNTB 11-30-2025
  • KOSS 10-28-2025
  • Dividend Yield
  • CNTB N/A
  • KOSS N/A
  • EPS Growth
  • CNTB N/A
  • KOSS N/A
  • EPS
  • CNTB N/A
  • KOSS N/A
  • Revenue
  • CNTB $1,965,000.00
  • KOSS $12,624,170.00
  • Revenue This Year
  • CNTB N/A
  • KOSS N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • KOSS N/A
  • P/E Ratio
  • CNTB N/A
  • KOSS N/A
  • Revenue Growth
  • CNTB N/A
  • KOSS 2.93
  • 52 Week Low
  • CNTB $1.23
  • KOSS $4.00
  • 52 Week High
  • CNTB $2.20
  • KOSS $8.59
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 50.63
  • KOSS 36.91
  • Support Level
  • CNTB $1.72
  • KOSS $4.82
  • Resistance Level
  • CNTB $1.90
  • KOSS $5.70
  • Average True Range (ATR)
  • CNTB 0.17
  • KOSS 0.25
  • MACD
  • CNTB 0.02
  • KOSS 0.01
  • Stochastic Oscillator
  • CNTB 61.53
  • KOSS 13.27

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: